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Abstract  
Objectives: to test whether or not the use of a polyethylene glycol (PEG) hydrogel applied as a 
matrix in combination with hydroxyapatite/tricalciumphosphate (HA/TCP) results in similar peri-
implant bone regeneration as traditional guided bone regeneration procedures. 
Materials and methods: In 12 beagle dogs, implant placement and peri-implant bone 
regeneration were performed two months after tooth extraction in the maxilla. Two standardized 
box-shaped defects were created and dental implants were placed in the center of the defects 
with a dehiscence of 4mm. Four treatment modalities were randomly applied: HA/TCP mixed 
with a synthetic PEG hydrogel (PEG), HA/TCP mixed with a synthetic PEG hydrogel supplemented 
with an RGD sequence (PEG-RGD), HA/TCP covered with a native collagen membrane (CM), no 
bone augmentation (empty). After a healing period of 8 or 16 weeks, Micro CT and histological 
analyses were performed.  
Results: Histomorphometric analysis revealed a greater relative augmented area (AA/TAA) for 
groups with bone augmentation (43.3%-53.9% at 8 weeks, 31.2%-42.8% at 16 weeks) 
compared to empty controls (22.9% at 8 weeks, 1.1% at 16 weeks). The median amount of 
newly formed bone was greatest in group CM at both time points. Regarding the first bone-to-
implant contact (fBIC), CM was statistically significantly superior to all other groups at 8 weeks.  
Conclusions: Bone can successfully be regenerated at peri-implant buccal dehiscence defects 
using traditional GBR techniques. The use of a PEG hydrogel applied as a matrix mixed with a 
synthetic bone substitute material, might lack a sufficient stability over time for this kind of 
defect. 
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Introduction 
Polyethylene glycol (PEG) hydrogel was introduced in dentistry as a biodegradable membrane for 
guided bone regeneration (GBR) procedures (Jung, et al. 2009, Jung, et al. 2009, Schwarz, et al. 
2010, Thoma, et al. 2012, Zambon, et al. 2012). A number of preclinical and clinical trials 
evaluated a degradable, form-stable PEG formulation with a long-term barrier function (Jung, et 
al. 2006). This PEG hydrogel demonstrated to be clinical effective in regenerating bone around 
dental implants similar to a native collagen membrane up to 5 years (Jung, et al. 2015). 
However, this dense PEG formulation showed a significantly higher exposure rate compared to 
sites grafted with a collagen membrane (Vierra, et al. 2014). In order to further enhance the 
clinical handling and to reduce the incidence of postoperative complications, numerous attempts 
were made to improve cell adhesion of the PEG hydrogel by testing less dense PEG formulations, 
associated with a reduction in the degradation time (Dahlin, et al. 2014, Halstenberg, et al. 
2002, Park, et al. 2004, Park, et al. 2005). Beside the variation of the density, the properties of 
PEG can be changed by the addition of molecules. Results from a preclinical trial in the rabbit 
skull demonstrated that the modification of the PEG network with RGD affected soft tissue 
attachment, bone regeneration, and the host's immunologic reaction (Thoma, et al. 2011). The 
dense network PEG demonstrated its ability to serve as a barrier membrane with the option of 
enhancing the soft tissue integration by adding a RGD sequence. It was also speculated that the 
looser network PEG hydrogel might have the potential to serve as a carrier or stand-alone 
material for localized bone regeneration and that the addition of RGD might further improve bone 
formation. In this context, PEG shall be used as a matrix mixed with a bone substitute material, 
not as a covering membrane (Hanseler, et al. 2012, Jung, et al. 2014). This is supported by a 
recent preclinical study (Thoma, et al. 2014), demonstrating that the addition of a loose network 
polyethylene glycol hydrogel to a synthetic bone substitute material (HA/TCP) increased new 
bone formation compared to the bone substitute material alone at 21 days. It was thereby 
concluded that the PEG hydrogel matrix might represent an interesting candidate to serve as a 
matrix for localized bone regeneration with or without the addition of a bone substitute material. 
It was also concluded that further studies are needed to confirm these results to apply the 
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combination of a loose network polyethylene glycol hydrogel and a bone substitute material in 
more challenging defect models and for guided bone regeneration procedures at implant sites.  
 
The aim of the present study was therefore to test whether or not the use of a polyethylene 
glycol (PEG) hydrogel applied as a matrix in combination with 
hydroxyapatite/tricalciumphosphate (HA/TCP) results in similar peri-implant bone regeneration 
as a control treatment using a membrane covering the same bone substitute (HA/TCP). 
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Materials and methods 
The article was written in accordance with the guidelines of the ARRIVE (Animal research: 
Reporting of in vivo experiments) protocol (Kilkenny, et al. 2010). The protocol was approved by 
the local ethical committee prior to the beginning of the experiment and the study was 
performed at the animal laboratory of Yonsei university, Seoul, South Korea. 
Animals 
A total of 12 male beagle dogs with a fully developed permanent dentition and healthy 
periodontal tissues were included in this study. Four weeks prior to the experiment and during 
the entire study, the dogs were fed with a soft-food diet and water ad libitum. At the beginning, 
the animals had a mean age of 18 months and a mean weight of 15 kg. All experiments were 
performed at the animal laboratory accredited by Association for Assessment and Accreditation 
of Laboratory Animal (AAALAC) international, after ethical approval of the institutional Animal 
Care and Use Committee regarding animal selection, management, and surgery control. 
Guided bone regeneration materials 
The bone substitute material used in this study was a synthetic material consisting of HA/TCP 
granules (Straumann Bone Ceramic 500-1000µm, Straumann, Basel, Switzerland). The 
experimental polyethylene glycol hydrogel had a biodegradation of 4 weeks and was applied as a 
matrix for the bone substitute and RGD. No further membrane coverage was performed in these 
groups. 
Surgical procedures 
The surgical procedures were described in detail in a previous publication (Benic et al. 2015). In 
brief, all P4 and M1 were extracted in the maxilla. Following a healing period of 2 months, 
implant placement and peri-implant bone regeneration were performed. For that purpose, dogs 
were pre-medicated with medetomidine (0.005 mg/kg, intramusculary) and morphine (0.5 
mg/kg intramusculary). Subsequently, general anesthesia was induced by injection of propofol 
(2mg/kg intravenously). Isofluorane (1.5-2%) and O2 (100%) were used as inhalation 
anesthetics. The animals were monitored routinely and further analgesia was given if necessary 
within the first days following all surgical procedures. Following a mid-crestal incision between 
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the M2 and the canine and two vertical releasing incisions (mesial and distal to the edentulous 
area) the buccal and lingual alveolar bone plates were exposed. After removing all granulation 
tissue, the edentulous ridges were slightly flattened to obtain a bucco-oral width of at least 7 
mm. Two standardized box-shaped defects were created with a mesio-distal width of 4 mm, 
bucco-oral depth of 2mm and a vertical height of 4 mm using a straight fissure carbide bur. The 
defect sites were rinsed with sterile saline to completely remove any residual debris, and the 
dimensions of the defect were verified by using a periodontal probe. Subsequently, 8-mm-long 
and 4.1-mm-diameter dental implants (Straumann Bonelevel, Straumann, Basel, Switzerland) 
were placed in the center of the defects with a final peri-implant dehiscence of 4mm (Figure 1a). 
The buccal cortical bone plates were perforated and the following four treatment modalities 
randomly applied to the peri-implant defects: 
i. synthetic particulated bone substitute material (Straumann Bone Ceramic®, particle size 
0.25-1 mm, Straumann, Basel, Switzerland) mixed with a synthetic PEG hydrogel (Straumann, 
Basel, Switzerland) (PEG) 
ii. synthetic particulated bone substitute material (Straumann Bone Ceramic®, particle size 
0.25-1 mm, Straumann, Basel, Switzerland) mixed a synthetic PEG hydrogel supplemented with 
RGD (Straumann, Basel, Switzerland). (PEG-RGD) 
iii. synthetic particulated bone substitute material (Straumann Bone Ceramic®, particle size 
0.25-1 mm, Straumann, Basel, Switzerland) covered with a non-cross-linked native collagen 
membrane (Bio-Gide®, Geistlich Pharma AG, Wolhusen, Switzerland) (CM) 
iv. no further GBR procedure (empty) 
 
In groups PEG and PEG-RGD, the bone substitute material was mixed with the liquid PEG 
hydrogel and applied to the peri-implant defects (Figure 1b). In group CM, the bone substitute 
material was applied to the defect and then covered with the collagen membrane, thereby 
extending 1mm beyond the augmented margins (Figure 1c). No further treatment was applied in 
empty control sites (Figure 1c). Following periostal-releasing incisions, the mucoperiostal flaps 
were coronally advanced and primary wound closure was accomplished by placing horizontal 
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mattress sutures and interrupted sutures (Monosyn® 4.0 Glyconate Monofilament, B. Braun 
Tuttlingen, Germany). Sutures were removed 14 days after surgery (Figure 1d). 
After a healing period of 8 weeks (n=6) and 16 weeks (n=6), the animals were painlessly 
sacrificed with an overdose of sodium pentobarbital 3%. All surgical sites were macroscopically 
inspected and any incidences were recorded. The maxillae were block-resected including the 
surrounding soft tissues. 
 
Micro CT analyses 
A micro-CT (SkyScan 1072, SkyScan, Aartselaar, Belgium) was taken following block resection 
at a resolution of 35μm (100 kV, 100 μA). The obtained data set was processed and the region 
of interest reconstructed with three-dimensional (3D) software (OnDemand3D®, Cybermed, 
Seoul, Korea). The first bone to implant contact (fBIC) was measured on the lingual (fBIC_lCT) 
and buccal (fBIC_bCT) side of the implants to the nearest 0.1mm. Bucco-oral horizontal 
thickness (HT in mm) of the mineralized tissue was analyzed at the level of the implant shoulder 
(HT_0), at 2 mm (HT_2) and 4mm (HT_4) below the implant shoulder (Figure 2a-h). 
 
Histological preparation 
The specimens were fixed in 10% formalin for 2 weeks. After fixation, samples were grossly 
bisected at the center of the defect in a mesio-distal direction using the EXAKT cutting system 
(EXAKT® Apparatebau, Norderstedt, Germany). Specimens were dehydrated using an ascending 
series of alcohol and embedded in methacrylate-based resin to permit sectioning of bone with 
the bone graft and dentin in situ. Subsequently, the embedded blocks were polymerized and 
then fixed to the vacuum head of the EXAKT macro cutter. Sections were prepared with a 
thickness of approximately 100 µm. These sections were then ground and polished on the EXAKT 
micro grinder to a thickness of 15 µm, mounted on microscope slides and stained with 
hematoxylin-eosin. 
 
Histomorphometric analysis 
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One experienced investigator who was not aware of the specific experimental conditions 
performed all analyses. Images were captured with a digital camera (Leica Microsystems digital 
camera Type DFC 450) connected to a light microscope (Leica Microsystems microscope Type 
DM6000 B). For histomorphometrical analysis, digital images were evaluated using an image 
analysis software (Leica Microsystems software LAS V4.3 modules LAS Analysis Bundle and 
Leica Phase Expert).  For each central section, the following variables were assessed: 
- total defect area (mm2; TAA) 
- regenerated area (mm2; AA) 
- percentage of regenerated area within total defect area (%; AA/TAA) (Figure 3a) 
- the percentage of regenerated bone, bone substitute material and non-mineralized tissue 
within the augmented area (%) (Figure 3a) 
- first bone to implant contact (fBIC), measured from the implant shoulder to the first bone 
to implant contact on the buccal (fBIC_b) and lingual (fBIC_l) side (Figure 3b) 
For TAA and AA, the following volumes were excluded: 
- any augmented volume directly superior or lingual to the implant in its axial plane  
- any augmented volume inferior to the buccal extension of the inferior border of the 
defect  
- any augmented volume on either side of the defect in its mesio-distal aspect 
 
Statistical analysis 
Descriptive statistics included mean and standard deviation for the marginal bone levels, as well 
as median with minimum and maximum. These numbers are given for the two different time 
points, as well as for the four different implant types separately. Multiple mixed models were 
fitted to the dependent variables for each time point. In these four models, we adjusted for the 
potentially confounding factors individual dog (as random effect), treatment, side (right or left) 
and position of implant. Because of the small sample size, one could not investigate complex 
models with many factors and interaction terms. No correction for the multiple testing of the 
many dependent variables is applied because of the small study. As primary endpoint we 
considered the variable %AA/TAA. The level of significance was set at p<0.05. 
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Results 
Clinical findings 
All dogs were healthy during the entire study period and neither systemic nor local adverse 
events were observed and all implants were osseointegrated. 
Histomorphometric analysis 
Table 1.A shows the data at 8 weeks, table 1.B shows the data at 16 weeks. At 8 weeks, the 
median AA/TAA values were greater for groups with bone augmentation (PEG, PEG-RGD, CM) 
ranging between 43.3% for CM (min 14.5%, max 72.0%) and 53.9% for PEG (min 31.0%, max 
68.2%) compared to the empty control group with 22.9% (min 0.1%, max 48.2%)(Figure 4a-d). 
Between 8 and 16 weeks, the AA/TAA ratio decreased in all groups. At 16 weeks, the median 
AA/TAA ratios were between 31.2% for PEG-RGD (min 20.0%, max 50.0%) and 42.8% for CM 
(min 21.6%, max 51.2%) for groups with bone augmentation and 1.1% (min 0.0%, max 8.1%) 
for empty controls (Figure 5a-d). The treatment effects were not statistically significant 
(p=0.280) at 8 weeks, and significant (p<0.0001) at 16 weeks. At 16 weeks also the site had a 
significant (p<0.0001) impact, but the difference of AA/TAA at the two sites anterior (P4) and 
posterior (M1) is only about 2%. The median amount of newly formed bone was greatest in 
group CM 15.8% (min 6.8%, max 24.1%), lower in the two PEG groups (6.7% (min 2.1%, max 
10.9%) for PEG and 6.3% (min 3.6%, max 20.2%) for PEG-RGD) at 8 weeks. Empty control 
sites rendered a median amount of new bone formation of 7.0% (min 0.7%, max 17.6%). No 
statistically significant differences were observed between the 4 groups by the mixed linear 
model (p=0.108). At 16 weeks, the median values were highest for group CM at 17.7% (min 
11.0%, max 20.6%), whereas in the two PEG groups, the amount of bone was 7.6% (min 3.9%, 
max 22.3%) for PEG and 9.7% (min 3.5%, max 25.5%) for PEG-RGD, respectively. Empty 
control sites rendered only a minimal amount of new bone formation with 1.3% (min 0.0, max 
8.3%). Statistically significantly less bone formation was observed in group empty compared to 
all other groups (p<0.001, 0.018 and 0.026). In addition, the difference between group CM and 
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PEG was statistically significant (p=0.0388). 
All groups with bone augmentation (CM, PEG, PEG-RGD) kept the amount of bone substitute 
material to a similar percentage ranging between 11.3% (min 0.0%, max 32.8%) for group CM 
and 18.0% (min 7.8%, max 32.2%) for PEG-RGD at 8 weeks. These numbers decreased slightly 
to 16 weeks with group CM demonstrating the least amount of bone substitute material (11.2%, 
min 8.0%, max 20.6%). None of the comparisons revealed statistically significant differences 
between the groups (p=0.5203 at 8 weeks and p=0.7378 at 16 weeks).  
At both sacrifice time-points, the fBIC values were smaller on the lingual side compared to the 
buccal side. The respective median values on the buccal side ranged between 2.1mm (min 
0.7mm, max 4.4mm) (CM) and 3.7mm (min 1.3mm, max 5.2mm) (PEG-RGD). Group CM was 
statistically significantly superior to all other groups at 8 weeks (p= 0.002, 0.004, 0.026). At 16 
weeks, the median values ranged between 2.5mm (min 0.0mm, max 3.8mm) (PEG) and 3.8mm 
(min 1.4mm, max 4.8mm) (empty) at 16 weeks. PEG and CM were statistically significantly 
superior compared to empty controls (p=0.005 and <0.001). 
Micro CT analysis 
Similar to the histological measurements, the fBIC_CT values were smaller on the lingual 
compared to the buccal side (Figure 2a-h). The median values on the buccal side ranged 
between 2.0mm (min 0.9mm, max 3.5mm) (CM) and 3.2mm (min 2.2mm, max 3.8mm) (PEG-
RGD). Similar to the histological measurements, the fBIC_CT values decreased up to 16 weeks 
for all groups with bone augmentation (PEG, PEG-RGD, CM) and ranged between 1.0mm (min 
0.5mm, max 4.0mm) (CM) and 3.5mm (min 1mm, max 4.4mm) (empty) at 16 weeks. These 
differences were not significant at the two time points (p=0.547 and 0.104). 
The medians of the bucco-oral horizontal thickness of the mineralized tissue at the level of the 
implant shoulder (HT_0) were 0.00 for all groups, revealing no bone formation up to the implant 
shoulder at both time-points. At the level 2mm below the implant shoulder (HT_2), median 
values ranged between 0.2mm (min 0.0mm, max 0.6mm) (empty) and 1.8mm (min 0.0mm, 
max 2.2mm) (PEG) at 8 weeks, which were significantly different (p=0.044). Group PEG 
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rendered statistically significantly higher values compared to empty and CM (p=0.012 and 
0.033). In addition, PEG-RGD was statistically significantly superior compared to empty 
(p=0.036). The median values decreased in all groups up to 16 weeks, except for group CM 
(from 0.3mm (min 0.0mm, max 1.4mm) to 0.8mm (min 0.0mm, max 1.3mm). There were no 
significant differences at 4mm below the implant shoulder (HT_4) between the groups 
(p=0.526), but significant not relevant differences at 8 weeks (p=0.004). 
Other than mentioned, none of the differences between the four groups were statistically 
significant (p>0.05) (Table 1). 
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Discussion 
The present preclinical study revealed, based on histomorphometric and micro CT analyses, that 
bone can be successfully regenerated at peri-implant dehiscence defects using a synthetic bone 
substitute material in combination with a PEG hydrogel matrix without a barrier membrane or a 
collagen membrane without significant differences between these groups for most outcome 
measures. The study also demonstrated that in terms of i) the relative augmented area 
(%AA/TAA), the greatest regeneration can be expected at 8 weeks for all groups compared to 16 
weeks; ii) PEG hydrogel groups rendered roughly 50% of newly formed bone with values 
between 6.3% and 9.7% compared to 15.8% to 17.7% in the CM group, iii) the first bone to 
implant contact, none of the groups regenerated bone up to the implant shoulder neither at 8 
nor at 16 weeks, CM sites, however, were superior compared to all other groups. 
Guided bone regeneration at buccal dehiscence defects is considered to be a successful 
treatment modality to regenerate bone along the implant surfaces as documented by preclinical 
and clinical studies using various combinations of materials (Hammerle, et al. 2002). In the 
present study, the relative augmented area (%AA/TAA) peaked at 8 weeks with values around 
50% and then decreased up to 16 weeks, predominantly in the PEG hydrogel groups. In contrast 
to other studies with a similar critical size defect and comparable measuring techniques, 
relatively low values were obtained for all groups with bone augmentation (Jung, Lee, Park, 
Thoma, Hammerle & Jung 2014, Lee, et al. 2015, Thoma, Dard, Halg, Ramel, Hammerle & Jung 
2012). The amount of bone that can be regenerated depends on the surgical technique, the 
membrane and the membrane supporting bone or bone substitute material used. Empty controls 
unexpectedly showed new bone formation at 8 weeks, which disappeared again up to 16 weeks. 
Acute peri-implant defects were used in the present study. These sites have demonstrated to be 
relatively reactive and might explain bone formation in empty controls at the earlier time-point. 
Between 8 and 16 weeks, remodeling processes were initiated and some of the newly formed 
bone might have been lost due to these processes. This also indicates that bone formation at 
peri-implant defects undergo structural changes during a longer time period. All groups with 
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bone augmentation showed bone formation within the total defect area without statistically 
significant differences between the groups. However, the collagen membrane group revealed 
50% more newly formed bone compared to the PEG groups. PEG hydrogel used in the present 
study appeared to be degraded rather fast with a negative impact on new bone formation. This is 
in line with previous preclinical studies using this type of PEG hydrogel with a low network 
density in different settings (Thoma, Subramani, Weber, Luder, Hammerle & Jung 2011). In 
contrast to the classic GBR principle using a membrane, which keeps cells of faster growing 
adjacent tissues away from migrating into the augmented area, the combination of a bone 
substitute and a PEG hydrogel matrix follows a different concept (Hanseler, Jung, Jung, Choi, 
Cho, Hammerle & Weber 2012, Jung, Lee, Park, Thoma, Hammerle & Jung 2014). The clinical 
handling of such a putty material (PEG hydrogel plus bone substitute material) is relatively easy 
and clinically results in a stable augmented area. Histologic analyses, however, demonstrated 
that this initially and clinically achieved stability did not persist and bone formation eventually 
was limited compared to control sites with a collagen membrane. 
Ideally, bone regeneration at buccal dehiscence defects aims to regenerate bone up to the 
implant shoulder. Even though the vertical position of the implants was correct and a submerged 
healing mode was performed, none of the treatment modalities reached this goal. These results 
are in line with other studies using the same treatment modality (Lee, Lim, Lee, Hong, Choi & 
Jung 2015, Pereira, et al. 2015). One of the explanations could be that bone substitute materials 
were displaced. In an in vitro study, the displacement of GBR materials was evaluated following 
wound closure and suturing. The collagen membrane collapses in the coronal portion of the 
augmented site as long as it is not fixated with pins or a block of bone substitute is used instead 
of granules (Mir-Mari, et al. 2015). Interestingly, a potentially negative impact of implant 
surfaces exposed to soft tissues could not be demonstrated. In two clinical studies employing 
immediate implants with simultaneous GBR, long-term outcomes based on clinical data and 
CBCT analyses demonstrated stable soft tissues, even though 35% and 25% of the implants had 
no buccal bone plate based on CBCTs (Benic, et al. 2012, Kuchler, et al. 2015). 
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The relatively high fBIC values were also reflected by the measurements for the horizontal 
thickness. The influence of GBR procedures was predominantly visible at a level 2mm below the 
implant shoulder, whereas no bone regenerated more coronally, up to the implant shoulder. The 
horizontal thickness 4mm below the bone crest was defined by the native ridge contour since 
this was the apical border of the original peri-implant defect. PEG hydrogels reached higher 
values at a level 2mm below the implant shoulder at 8 weeks, but were undergoing greater 
remodeling process up to 16 weeks compared to the collagen membrane group. Various studies 
assessed the horizontal thickness following GBR procedures at buccal peri-implant dehiscence 
defects over time (Schneider, et al. 2014) (Jung, Halg, Thoma & Hammerle 2009, Zitzmann, et 
al. 1997). All data are based on clinical measurements and demonstrate a decrease of the 
augmented area of approximately 1mm over the course of 6 months. These clinical data also 
demonstrate that, during the healing phase, augmented bone/bone substitute materials are 
remodeled and that the horizontal thickness of the bone thereby decreases.  
Previous experimental studies showed early bone formation when RGD was applied on implant 
surfaces (Germanier, et al. 2006) and improved bone formation as well as more intimate contact 
to soft tissues when applied in combination with PEG hydrogels (Schneider, et al. 2011, Thoma, 
Subramani, Weber, Luder, Hammerle & Jung 2011). The amount of newly formed bone in the 
present study was higher with the addition of RGD, but did not reach statistically significant 
differences. The same applies for all other outcomes measures that were not significantly 
affected by RGD. Most of the positive effects of RGD found in other studies were measured at 
earlier time-points. Therefore, the influence of RGD might not be measurable at later follow-up 
time-points such as 8 or 16 weeks like in the present study. 
Comparing both PEG groups with the collagen membrane in terms of guided bone regeneration, 
few differences were observed. In brief, CM showed better results in terms of the first bone to 
implant contact and more bone formation at the later time-point. The PEG formulation with a low 
density might be suitable as a matrix for bone substitute materials and demonstrated a good 
clinical applicability and stability of the augmented area prior to wound closure. The relatively 
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fast degradation as reported in previous studies, might, however, have a negative impact on new 
bone formation and long-term space-maintenance (Thoma, Subramani, Weber, Luder, Hammerle 
& Jung 2011). 
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Conclusions 
Bone can be regenerated successfully at peri-implant buccal dehiscence defects in dogs using a 
combination of a synthetic bone substitute and a collagen membrane or a PEG hydrogel matrix. 
Minimal differences were observed between the groups with bone augmentation for most 
outcome measures. The CM group, however, demonstrated to be superior in terms of 
regenerated bone and the first bone-to-implant contact. The use of a PEG hydrogel with or 
without RGD, applied as a matrix mixed with a synthetic bone substitute material, might lack a 
sufficient stability over time for this kind of peri-implant defect. 
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Table 1. Descriptive statistics with means, standard deviations and medians of 
histomorphometric measurements within the region of interest and micro-CT analysis by 
matrix/membrane A. at 8 weeks; B. at 16 weeks; SD=standard deviation. PEG = synthetic 
particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD = synthetic particulated 
bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD; CM = 
synthetic particulated bone substitute material covered with a non-cross-linked native collagen 
membrane; empty = no further GBR procedure. 
 
Figure 1a Implant placed after flap elevation and creation of the bony defects at the sites M1 
(left) and P4 (right). 
 
Figure 1b. Material application of PEG-RGD at P4 (left) and PEG at M1 (right). PEG = synthetic 
particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD = synthetic particulated 
bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD. 
 
Figure 1c Material application of CM at P4 (left) and M1 remaining empty control (right). CM = 
synthetic particulated bone substitute material covered with a non-cross-linked native collagen 
membrane. 
 
Figure 1d Suture removal at 14 days.  
 
Figure 2a-d Micro-CT at 8 weeks for PEG (2a), PEG-RGD (2b), CM (2c), empty control (2d). PEG 
= synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD = synthetic 
particulated bone substitute material mixed a synthetic PEG hydrogel supplemented with RGD; 
CM = synthetic particulated bone substitute material covered with a non-cross-linked native 
collagen membrane. Micro-CT measurements of buccal and lingual first bone to implant contact 
(fBIC_CT) are shown in blue. Horizontal thickness measurements (red) at the buccal implant 
shoulder (HT_0) and at 2 mm (HT_2) respectively 4mm (HT_4) below the implant shoulder. 
Green measurements determine the height at which the HT measurements were performed. 
 
Figure 2e-h Micro-CT at 16 weeks for PEG (2e), PEG-RGD (2f), CM (2g), empty control (2h). 
PEG = synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD = 
synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented 
with RGD; CM = synthetic particulated bone substitute material covered with a non-cross-linked 
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native collagen membrane. Micro-CT measurements of buccal and lingual first bone to implant 
contact (fBIC_CT) are shown in blue. Horizontal thickness measurements (red) at the buccal 
implant shoulder (HT_0) and at 2 mm (HT_2) respectively 4mm (HT_4) below the implant 
shoulder. Green measurements determine the height at which the HT measurements were 
performed. 
 
Figure 3a Histomorphometric analysis within the defined region of interest (ROI). 
 
Figure 3b Histologic evaluation of the first bone to implant contact on the buccal und lingual 
aspect of the implant. 
 
Figure 4a-d Histology at 8 weeks for PEG (3a), PEG-RGD (3b), CM (3c), empty control (3d). 
PEG = synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD = 
synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented 
with RGD; CM = synthetic particulated bone substitute material covered with a non-cross-linked 
native collagen membrane. BS = bone substitute, B = bone, NB = new bone 
 
Figure 5a-d Histology at 16 weeks for PEG (4a), PEG-RGD (4b), CM (4c), empty control (4d). 
PEG = synthetic particulated bone substitute mixed a synthetic PEG hydrogel; PEG-RGD = 
synthetic particulated bone substitute material mixed a synthetic PEG hydrogel supplemented 
with RGD; CM = synthetic particulated bone substitute material covered with a non-cross-linked 
native collagen membrane. BS = bone substitute, B = bone, NB = new bone 
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Table 1 A 
  
 Variable PEG PEG-RGD CM empty 
n Mean ± SD Median Min;Max n Mean ± SD Median Min;Max n Mean ± SD Median Min;Max n Mean ± SD Median Min;Max 
Histo-
morpho-
metric 
 
analysis 
AA/TAA 6 52.6% ± 
12.9% 
53.9% 31.0%; 
68.2% 
6 49.7% ± 
16.8% 
51.2% 25.8%; 
74.0% 
6 46.0% ± 
21.7% 
43.3% 14.5%; 
72.0% 
5 23.8% ± 
22.0% 
22.9% 0.1%; 
48.2% 
Newly formed 
bone 
6 6.6% ± 
3.1% 
6.7% 2.1%; 
10.9% 
6 8.9% ± 
6.7% 
6.3% 3.6%; 
20.2% 
6 15.0% ± 
7.1% 
15.8% 6.8%; 
24.1% 
5 7.5% ± 
6.4% 
7.0% 0.7%; 
17.6% 
Bone 
substitute 
6 15.0% ± 
7.2% 
16.9% 3.5%; 
24.4% 
6 20.1% ± 
9.8% 
18.0% 7.8%; 
32.2% 
6 13.9% ± 
11.9% 
11.3% 0.0%; 
32.8% 
5 0.0% ± 
0.0% 
0.0% 0.0%; 
0.0% 
fBIC_buccal 6 3.7mm ± 
0.4mm 
3.7mm 3.0mm; 
4.0mm 
6 3.6mm ± 
1.3mm 
3.7mm 1.3mm; 
5.2mm 
6 2.4mm ± 
1.5 mm 
2.1mm 0.7mm; 
4.4mm 
6 3.0mm ± 
1.1mm 
3.2mm 1.2mm; 
4.2mm 
fBIC_lingual 6 0.3mm ± 
0.2mm 
0.3mm 0.0mm; 
0.5mm 
6 0.6mm ± 
0.5mm 
0.5mm 0.0mm; 
1.2mm 
6 0.6mm ± 
0.2mm 
0.6mm 0.4mm; 
0.9mm 
6 0.5mm ± 
0.4mm 
0.3mm 0.1mm; 
1.0mm 
Micro-CT fBIC_buccal_
CT 
6 2.3mm ± 
1.7mm 
2.7mm 0.0mm; 
4.5mm 
6 3.1mm ± 
0.6mm 
3.2mm 2.2mm; 
3.8mm 
5 2.1mm ± 
1.0mm 
2.0mm 0.9mm; 
3.5mm 
6 3.1mm ± 
0.8mm 
3.0mm 2.2mm; 
4.0mm 
fBIC_lingual_
CT 
6 1.0mm ± 
1.6mm 
0.3mm 0.0mm; 
4.0mm 
6 0.7mm ± 
0.6mm 
0.6mm 0.0mm; 
1.5mm 
5 1.3mm ± 
0.6mm 
1.4mm 0.3mm; 
1.8mm 
6 0.3mm ± 
0.3mm 
0.2mm 0.0mm; 
0.7mm 
HT_0 6 0.2mm ± 
0.3mm 
0.0mm 0.0mm; 
0.6mm 
6 0.1mm ± 
0.3mm 
0.0mm 0.0mm; 
0.6mm 
5 0.0mm ± 
0.0mm 
0.0mm 0.0mm; 
0.0mm 
6 0.0mm ± 
0.0mm 
0.0mm 0.0mm; 
0.0mm 
HT_2 6 1.5mm ± 
0.8mm 
1.8mm 0.0mm; 
2.2mm 
6 1.2mm ± 
0.8mm 
1.3mm 0.0mm; 
2.1mm 
5 0.4mm ± 
0.6mm 
0.3mm 0.0mm; 
1.4mm 
6 0.2mm ± 
0.3mm 
0.2mm 0.0mm; 
0.6mm 
HT_4 6 1.7mm ± 
0.3mm 
1.8mm 1.4mm; 
2.1mm 
6 1.5mm ± 
0.5mm 
1.5mm 0.9mm; 
2.1mm 
5 1.4mm ± 
0.5mm 
1.2mm 1.0mm; 
2.3mm 
6 1.6mm ± 
0.4mm 
1.5mm 1.2mm; 
2.3mm 
 
 
 
Table 1 B 
  
 Variable PEG PEG-RGD CM empty 
n Mean ± SD Median Min;Max n Mean ± SD Median Min;Max n Mean ± SD Median Min;Max n Mean ± SD Median Min;Max 
Histo-
morpho-
metric 
 
analysis 
AA/TAA 6 37.1% ± 
5.6% 
38.3% 27.2%; 
44.1% 
6 32.2% ± 
10.0% 
31.2% 20.0%; 
50.0% 
6 39.7% ± 
10.1% 
42.8% 21.6%; 
51.2% 
5 2.5% ± 
3.2% 
1.1% 0.0%; 
8.1% 
Newly formed 
bone 
6 9.6% ± 
6.6% 
7.6% 3.9%; 
22.3% 
6 11.8% ± 
7.5% 
9.7% 3.5%; 
25.5% 
6 16.7% ± 
3.7% 
17.7% 11.0%; 
20.6% 
5 2.7% ± 
3.3% 
1.3% 0.0%; 
8.3% 
Bone 
substitute 
6 14.1% ± 
6.4% 
12.4% 8.7%; 
25.6% 
6 14.1% ± 
4.5% 
12.3% 8.6%; 
20.6% 
6 12.0% ± 
4.5% 
11.2% 8.0%; 
20.6% 
5 0.0% ± 
0.0% 
0.0% 0.0%; 
0.0% 
fBIC_buccal 6 2.1mm ± 
1.6mm 
2.5mm 0.0mm; 
3.8mm 
6 2.4mm ± 
1.5mm 
3.1mm 0.2mm; 
3.8mm 
6 2.5mm ± 
0.9mm 
3.0mm 1.0mm; 
3.3mm 
6 3.5mm ± 
1.2mm 
3.8mm 1.4mm; 
4.8mm 
fBIC_lingual 6 0.1mm ± 
0.1mm 
0.0mm 0.0mm; 
0.3mm 
6 0.4mm ± 
0.6mm 
0.1mm 0.0mm; 
1.4mm 
6 0.5mm ± 
0.4mm 
0.6mm 0.0mm; 
0.9mm 
6 0.3mm ± 
0.4mm 
0.2mm 0.0mm; 
0.9mm 
Micro-CT fBIC_buccal_
CT 
5 2.2mm ± 
0.9mm 
2.0mm 0.9mm; 
3.1mm 
5 2.0mm ± 
1.1mm 
2.0mm 0.5mm; 
3.1mm 
6 1.5mm ± 
1.3mm 
1.0mm 0.5mm; 
4.0mm 
6 3.2mm ± 
1.3mm 
3.5mm 1.0mm; 
4.4mm 
fBIC_lingual_
CT 
5 0.2mm ± 
0.2mm 
0.3mm 0.0mm; 
0.4mm 
5 0.4mm ± 
0.3mm 
0.4mm 0.0mm; 
0.8mm 
6 0.7mm ± 
0.9mm 
0.4mm 0.0mm; 
2.3mm 
6 0.5mm ± 
0.4mm 
0.5mm 0.0mm; 
1.0mm 
HT_0 5 0.0mm ± 
0.0mm 
0.0mm 0.0mm; 
0.0mm 
5 0.0mm ± 
0.0mm 
0.0mm 0.0mm; 
0.0mm 
6 0.0mm ± 
0.0mm 
0.0mm 0.0mm; 
0.0mm 
6 0.0mm ± 
0.0mm 
0.0mm 0.0mm; 
0.0mm 
HT_2 5 0.4mm ± 
0.5mm 
0.1mm 0.0mm; 
1.1mm 
5 0.4mm ± 
0.4mm 
0.5mm 0.0mm; 
0.9mm 
6 0.7mm ± 
0.5mm 
0.8mm 0.0mm; 
1.3mm 
6 0.2mm ± 
0.5mm 
0.0mm 0.0mm; 
1.1mm 
HT_4 5 1.6mm ± 
0.6mm 
1.8mm 0.9mm; 
2.3mm 
5 1.4mm ± 
0.6mm 
1.2mm 0.7mm; 
2.2mm 
6 1.5mm ± 
0.9mm 
1.6mm 0.3mm; 
2.6mm 
6 0.6mm ± 
0.6mm 
0.5mm 0.0mm; 
1.6mm 
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